EUVIMEDEUVIMED entdecken
Crossref

Elevating nucleic acid delivery via a stable anionic peptide-dextran ternary system

Alex Cheng iD, Ying Liu iD, Hai-Qing Song iD

Biointerphases · 2023

DOI: 10.1116/6.0003084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biointerphases, 2023. Verfasst von Alex Cheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, University of Illinois at Chicago, Chicago, Illinois 60607. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid-based therapies hold promise for treating previously intractable diseases but require effective delivery vectors to protect the therapeutic agents and ensure efficient transfection. Cationic polymeric vectors are particularly notable for their adaptability, high transfection efficiency, and low cost, but their positive charge often attracts blood proteins, causing aggregation and reduced transfection efficiency. Addressing this, we designed an anionic peptide-grafted dextran (Dex-LipE5H) to serve as a cross-linkable coating to bolster the stability of cationic polymer/nucleic acid complexes. The Dex-LipE5H was synthesized through a Michael addition reaction, combining an anionic peptide (LipE5H) with dextran modified by divinyl sulfone. We demonstrated Dex-lipE5H utility in a novel ternary nucleic acid delivery system, CDex-LipE5H/PEI/nucleic acid. CDex-LipE5H/PEI/nucleic acid demonstrated lower cytotoxicity and superior anti-protein absorption ability compared to PEI/pDNA and Dex-LipE5H/PEI/pDNA. Most notably, the crosslinked CDex-LipE5H/PEI/pDNA demonstrated remarkable transfection performance in HepG2 cells, which poses significant transfection challenges, even in a medium with 20% serum. This system’s effective siRNA interference performance was further validated through a PCSK9 gene knockdown assay. This investigation provides novel insights and contributes to the design of cost-effective, next-generation nucleic acid delivery systems with enhanced blood stability and transfection efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Nucleic AcidsDextransDNAPolyethyleneimineTransfectionPolymersPeptidesPlasmids

Substanzen

PCSK9 protein, humanProprotein Convertase 9DextransNucleic AcidsDNAPolyethyleneiminePolymersPeptides

Autor:innen und Institutionen

  • Department of Chemical Engineering, University of Illinois at Chicago, Chicago, Illinois 60607.
  • Engineering Research Center of Clinical Functional Materials and Diagnosis and Treatment Devices of Zhejiang Province, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325000, China.

ORCID-Profile: Alex Cheng, Ying Liu, Hai-Qing Song

Zitieren

APA

Cheng, A., Liu, Y., & Song, H. Q. (2023). Elevating nucleic acid delivery via a stable anionic peptide-dextran ternary system. Biointerphases. https://doi.org/10.1116/6.0003084

Vancouver

Cheng A, Liu Y, Song HQ. Elevating nucleic acid delivery via a stable anionic peptide-dextran ternary system. Biointerphases. 2023. doi:10.1116/6.0003084

BibTeX
@article{Cheng2023,
  author = {Cheng, Alex and Liu, Ying and Song, Hai-Qing},
  title = {Elevating nucleic acid delivery via a stable anionic peptide-dextran ternary system},
  journal = {Biointerphases},
  year = {2023},
  doi = {10.1116/6.0003084}
}
Kostenlos starten →